Roche has bought 540,000 of its own shares, the company said on Friday, as a member of its controlling family group scaled back their investment in voting shares at the pharmaceuticals maker.
https://www.pharmalive.com/wp-content/uploads/2022/05/New-class-of-cancer-drugs-down-not-out-after-Roche-trial-setback-–-analysts-Reuters-5-11-22.jpg503960Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-02-10 04:32:282023-02-10 12:33:02Roche buys back shares as family group reduces voting stake in drugmaker